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1. INTRODUCTION 
Hyperlipidemia or Hyperlipoproteinemia involves abnormally elevated levels 
of any or all lipids and or lipoproteins in the blood. It is the most common form of 
dyslipidemia which includes any abnormal lipid levels. Hyperlipidemias are divided 
into primary and secondary subtypes. Primary hyperlipidemia is usually due to 
genetic causes (such as a mutation in a receptor protein), while secondary 
hyperlipidemia arises due to other underlying causes such as diabetes. Lipid and 
lipoprotein abnormalities are common in the general population, and are regarded as a 
modifiable risk factor for cardiovascular disease due to their influence on 
atherosclerosis. In addition, some forms may predispose to acute pancreatits1, 2.  
It is a secondary metabolic dysregulation associated with diabetes, but also 
represents increased risk factor for development of diabetes3, 4,5. Besides the cause 
effect relationship with diabetes, elevated serum level of triglycerides, cholesterol and 
LDL are risk factors for the premature development of cardiovascular diseases like 
atherosclerosis, hypertension, coronary heart diseases etc6, 7. 
Hypercholesterolemia has been found to induce oxidative stress in various 
organs such as the liver, heart and kidney.  Increased plasma lipid levels mainly total 
cholesterol; triglycerides and LDL along with decrease in HDL are known to cause 
hyperlipidemia which is core in initiation and progression of atherosclerosis impasse8. 
Hyperlipidemia is deeply involved in the etiology of atherosclerosis. 
Moreover, results of various studies have revealed that hyperlipidemia is an important 
risk factor of coronary artery disease. Thus much attention is being given to primary 
and secondary prevention of hyperlipidemia. As a result, antihyperlipidemic agents 
having various pharmacological actions are being tested clinically. Hyperlipidemia in 
many cases in the modern age is caused by over-investigation of alcohol or foods; 
Attention is also being paid to treatment of patients with hyperlipidemia using strict 
management and appropriate exercise9. Hence the present study is designed to 
evaluate the Antihyperlipidemic activity using herbal extracts. 
is the most common cause of coronary heart disease (CHD) and related mortality. The 
first observable event in the process of atherosclerosis is the accumulation of plaque 
(cholesterol from low-density lipoproteins, calcium, and fibrin) in the endothelium of 
large and medium size arteries. 
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Fig 1. Cholesterol sources 
Lipids are classified according to their structure into simple, compound and 
derived lipids based on the hydrolysis, which result in breaking off the fatty acids, 
leaving free fatty acids and a glycerol, using up three water molecules. Simple lipids 
are esters of fatty acids with various types of alcohol. They are distinguished into fats 
and oils. Compound lipids contain an inorganic or organic group in addition to fatty 
acids and glycerol. They include phospholipids, glycolipids and lipoproteins. Finally, 
derived lipids are obtained by hydrolysis of simple and compound lipids. These lipids 
contain glycerol and other alcohols. The main source of dietary lipids is through the 
intake of (TG) which can be found as fats or oils. 
 
Fig 2. Normal & atherotic artery 
Lipids are important in maintaining the structure of cell membrane 
(cholesterol, phospholipids), steroid hormone synthesis (cholesterol), and energy 
metabolism (TG and fatty acid). 
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Pathophysiology 
  Hypercholesterolemia develops as a consequence of abnormal lipoprotein 
metabolism, mainly reduction of LDL receptor expression or activity, and 
consequently diminishing hepatic LDL clearance from the plasma. It is a major 
predisposing risk factor for the development of atherosclerosis. This mechanism is 
classically seen in familial hypercholesterolemia and when excess saturated fat or 
cholesterol is ingested. In addition, excessive production of VLDL by the liver, as 
seen in familial combined hyperlipidemia and insulin resistance states such as 
abdominal obesity and Type -II diabetes, can also induce hypercholesterolemia or 
mixed dyslipidemia.  
  A current theory for the initiating event in atherogenesis is that apoprotein B-
100 containing lipoproteins are retained in the sub endothelial space, by means of a 
charge-mediated interaction with extracellular matrix and proteoglycans. This allows 
reactive oxygen species to modify the surface phospholipids and unesterified 
cholesterol of the small LDL particles. Circulating LDL can also be taken up into 
macrophages through unregulated scavenger receptors. As a result of LDL oxidation, 
isoprostanes are formed. Isoprostanes are chemically stable, free radical-catalyzed 
products of arachidonic acid, and are structural isomers of conventional 
prostaglandins. Isoprostane levels are increased in atherosclerotic lesions, but they 
may also be found as F2 isoprostanes in the urine of asymptomatic patients with 
hypercholesterolemia.  
  A strong association exists between elevated plasma concentrations of 
oxidized LDL and CHD. The mechanisms through which oxidized LD promotes 
atherosclerosis are multiple and include damage to the endothelium, induction of 
growth factors, and recruitment of macrophages and monocytes. Vasoconstriction in 
the setting of high levels of oxidized LDL seem to be related to a reduced release of 
the vasodilator nitric oxide from the damaged endothelial wall as well as increased 
platelet aggregation and thromboxane release. Smooth muscle proliferation has been 
linked to the release of cytokines from activated platelets. The state of 
hypercholesterolemia leads invariably to an excess accumulation of oxidized LDL 
within the macrophages, thereby transforming them into "foam" cells. The rupture of 
these cells can lead to further damage of the vessel wall due to the release of oxygen 
free radicals, oxidized LDL, and intracellular enzymes. This is a metabolically 
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complex disease of lipid -lipoprotein metabolism and the exact etiology is not fully 
appreciated. The familial type in schnauzers may involve defects lipoprotein lipase 
and/or Apoprotein C-II, a required cofactor for lipoprotein lipase activity. This defect 
causes a failure to breakdown chylomicrons and VLDL, and results in excessive 
levels of circulating triglycerides. It is the elevated concentration of triglycerides that 
is responsible for the clinical signs. 
 Pathways of Lipid Transport  
Cholesterol is absorbed from the intestine and transported to the liver by 
chylomicron reminants, which are taken up by the low density lipoprotein (LDL)- 
receptor related protein (LRP). Hepatic cholesterol enters the circulation as verylow-
density lipoprotein (VLDL) and is metabolized to remnant lipoproteins after 
lipoprotein lipase removes triglyceride. The remnant lipoproteins are removed by 
LDL receptors (LDL-R) or further metabolized to LDL and then removed by these 
receptors. Cholesterol is transported from peripheral cells to the liver by high-density 
lipoprotein (HDL). Cholesterol is recycled to LDL and VLDL by cholesterol-ester 
transport protein (CETP) or is taken up in the liver by hepatic lipase. Cholesterol is 
excreted in bile. The points in the process that are affected by the five primary 
lipoprotein disorders and familial hypertriglyceridemia (FHTG), Familial combined 
hyperlipidemia (FCHL), remnant removal disease (RRD, also known as familial dys-
beta-lipoproteinemia), Familial hypercholesterolemia (FH), and hypo-alpha- 
lipoproteinemia shown. The effects of drug therapy can also be understood from these 
pathways. Statins decrease the synthesis of cholesterol and the secretion of VLDL and 
increase the activity of LDL receptors. Bile-acid binding resins increase the secretion 
of bile acids. Nicotinic acid decreases the secretion of VLDL and the formation of 
LDL and increases the formation of HDL.  
Fibrates decrease the secretion of VLDL and increase the activity of 
lipoprotein lipase, thereby increasing the removal of triglycerides. d. LDL cholesterol: 
The low density lipoprotein (LDL) cholesterol (sometimes called "bad cholesterol") is 
a more accurate predictor of CHD than total cholesterol. Where all concentrations are 
given in mg/dl. Higher LDL cholesterol concentrations have been associated with an 
increased incidence of CHD in a large number of studies. They have longest plasma 
half-life, of about 1.5 days. Ideally, LDL cholesterol levels should be less than 100 
mg/dl in patients who have had CHD in the past or CHD risk equivalents. People with 
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levels of 160 mg/dl or higher have a high risk of CHD. Intermediate levels — 130 to 
159 mg/dl — predict an intermediate risk of CHD. LDL particles are finally delivered 
to hepatic and certain extra hepatic tissues for further liposomal degradation to release 
the cholesterol which can be utilized in cell membrane formation. The LDL 
cholesterol can only be determined accurately on a blood test after fasting for 12 to 14 
hours. e. IDL cholesterol:- These are the lipoproteins obtained when the triglyceride 
content of VLDL are partially digested in capillaries by the action of extra hepatic 
lipoprotein lipase and having the diameter of 20-35 nm. f. Triglycerides: Elevated 
levels of triglycerides are also associated with an increased risk of CHD. 
 • Normal - less than 150 mg/dl (1.69 mmol/l) 
 • Borderline high - 150 to 199 mg/dl (1.69 to 2.25 mmol/l) 
• High - 200 to 499 mg/dl (2.25 to 5.63 mmol/l) 
• Very high - greater than 500 mg/dl (5.65 mmol/l) Triglycerides in mg/dl = Abs 
T/Abs STD×200 Like LDL cholesterol, triglycerides should only be measured in a 
blood specimen obtained after fasting for 12 to 14 hours. 
 This is a group of heterogeneous lipoprotein having low lipid content and is also 
called as good cholesterol. HDL enhances the removal of cholesterol from the arterial 
wall. Hence, chances of development of atherosclerotic lesions are more when HDL 
value falls below normal.  
Similar to total cholesterol, the HDL-cholesterol can be measured in blood specimen 
without fasting.  
HDL cholesterol mg/dl = Abs TH/Abs STD×50  
 
Conversion Factors: Cholesterol: mmol/L x 38.7 = mg/dl mg/dl x 0.026 = mmol/L 
Triglycerides: mmol/L x 885.5 = mg/dl mg/dl x 0.0113 = mmol/L Phospholipids: g/L 
x 0.01 = mg/dl mg/dl x 10 = g/L Simple blood tests can determine levels of 
Lipoproteins. Including Total cholesterol, LDL and HDL cholesterol, and 
triglycerides. 
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Causes 
 Hyperlipidemia is caused by lifestyle habits or treatable medical conditions. 
Lifestyle habits include obesity, sedentary life without exercise, smoking. Medical 
diseases that may result in Hyperlipidemia are diabetes, kidney disorders, pregnancy, 
and an under active thyroid gland. Common secondary causes of 
hypercholesterolemia are hypothyroidism, pregnancy, and Kidney failure. Common 
secondary causes of hypertriglyceridemia are diabetes, excess alcohol intake, obesity, 
and certain prescription medications. 
 Symptoms based diagnosis of Hyperlipidemia 
  Generally hyperlipidemia condition does not show apparent symptoms and it 
is discovered and diagnosed during routine examination or evaluation for 
atherosclerotic cardiovascular disease. However, deposits of cholesterol may be 
formed under the skin in individuals with familial forms of the disorder or in persons 
with very high levels of cholesterol in the blood. In individuals with 
hypertriglyceridemia, several pimple-like lesions may be developed across their 
bodies. Pancreatitis, a severe inflammation of the pancreas that may be lifethreatening 
can also be developed due to extremely high levels of triglycerides. For diagnosis of 
hyperlipidemia, levels of total cholesterol, low density lipoprotein cholesterol, high 
density lipoprotein cholesterol, and triglycerides are measured in blood sample. It is 
important to note that the lipid profile should be measured in all adults 20 years and 
older, and the measurement should be repeated after every 5 years. Food or beverages 
may increase triglyceride levels temporarily, so people must fast at least 12 hours 
before giving their blood samples. Blood tests are carried out to identify the specific 
disorders, when lipid levels in the blood are very high. Specific disorders may include 
several hereditary disorders, which produce different lipid abnormalities and have 
different risks. 
Laboratory Testing 
Patients are subjected to fasting for at least 12 hours before collecting the 
blood sampling. Because, chylomicron clearance can take up to 10 hours. However, a 
fasted sample is not required for simple cholesterol screening. Laboratory testing of 
the lipid profile measures total plasma cholesterol, HDL, and triglycerides levels 
directly. VLDL cholesterol levels are calculated by dividing the triglyceride value by 
5. LDL cholesterol is calculated by subtracting HDL cholesterol and VLDL 
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cholesterol from total cholesterol. When triglycerides are above 400 mg/dl, LDL 
calculation is inaccurate, and specialized laboratory tests are required. 
Types of hyperlipidemia: 
 Hyperlipidemia may basically be classified as either familial (also called 
primary) caused by specific genetic abnormalities, or acquired (also called secondary) 
when resulting from another underlying disorder that leads to alterations in plasma 
lipid and lipoprotein metabolism. Also, hyperlipidemia may be idiopathic, that is, 
without known cause. 
Diagnosis of hyperlipidemia:  
Many hyperlipidemic individuals are detected as a result of screening 
procedures, either in the course of 'health-screening' or of 'profiling' of patients. 
Fasting serum TG concentration is generally >1000 mg/dL (>11.2 mmol/L), and 
sometimes can exceed 10.000 mg/dL (112 mmol/L) (5). Concomitant lipid 
abnormalities include a modest elevation in serum total cholesterol, with decreases in 
low density lipoprotein cholesterol (LDL) and high density lipoprotein cholesterol 
(HDL- c) (6). A full lipid profile including plasma cholesterol, plasma TG and HDL-c 
should be obtained following an overnight fast (12-14 hours). In routine practice, 
LDL concentration (mg/dL) is estimated indirectly from the measured levels of TG, 
HDL-c, and total cholesterol (TC) using the Friedewald equation: LDL = TC – HDL – 
(TG / 5).When concentrations are expressed in mmol/L, TG is divided by 2.17 instead 
of others. 
 
Fig 3. Blockage of arteries 
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Treatment  
  The main aim of treatment in the majority of hyperlipidaemic patients is to 
reduce the risk of developing premature vascular disease (primary prevention) or the 
occurrence of further vascular events in those with clinical vascular disease 
(secondary prevention). The non pharmacological treatment of hyperlipdemia 
depends on life style modification including diet control, weight loss and exercise (8). 
While drug therapy includes: Statins, Fibrates, Nicotinic acid, Omega-3 fatty acids 
(fish oils), Ezetimibe (9). 
Hyperlipidemia 
 
Definition:  
- Abnormally high level of any lipoprotein species. 
- Hyperlipoproteinemia (hyperlipidemia) . any type of lipid 
- Hyperlipemia (hypertriglycridemia). only TG 
Causes: 
- 1ry hyperlipidemia         genetic factors. 
- 2ry hyperlipidemia         Disease . 
- Liver & biliary disease  
- Hypothyroidism        ( metabolism ) 
- Obesity – diabetes  
- Drug – oral contraceptives 
- Alcohol  
Clinical consequences : 
- Atherosclerosis  
- Coronary heart disease  
- Acute pancreatitis 
Lipoprotein classification : 
- 5 classes & lipoprotein 
1- Chylomicron  
Largest lipoprotein  
Transport dietary TGs 
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2- VLDL 
Carry endogenous TGs synthesized in liver to peripheral tissue  
3- IDL- intermediate density lipoprptein. Remnant of VLDL 
4- LDL- low density lipoprotein. Bad , the oxidized form of LDL is v. 
dangerous           ischemic heart disease.HLD- high density lipoprptein. 
Good 
Important points in the figure : 
- Type II a  : increased risk of ischemic heart disease .(more dangerous LDL) 
- Type II b : VLDL over production w\LDL 
- Type III: IDL  
- Type IV: VLDL high  
- Type V: mixed lipids increase. 
Classification of antihyperlipidemia : 
1- Fibric acid derivatives (fibrates) 
2- Bile acid binding resin 
3- Statins . HMG-coA reductase inhibitors 
4- Niacin (nicotinic acid ) 
5- Ezetimibe 
1. Fibrates 
- Clofibrate (no longer used) 
- Fenofibrate (tricor) 
- Gemfibrozil (lopid) 
- Besafibrate  
- Cilorofibrate 
Mechanism of action : 
- Are ligands for nuclear transcription receptors called peroxisome proliferator 
activated receptor – alpha (PPAR-a) 
- Increase lipoprotein lipase activity 
- Increase lipolysis of TGs (VLDL + chylomicrons)  
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Pharmacological action: 
- Increase VLDL clearance. 
- Reduce hepatic VLDL production. 
- Mainly reduce VLDL , Moderately reduce LDL. 
Pharmacokinetics: 
- Finofibrate is a prodrug (ester). 
- Well absorbed orally. 
- Bound to plasma proteins. 
- Cross the placenta 
- Metabolized in liver (enterohepatic  circulation). 
- Renal excretion as glucouronides. 
- Plasma 1\2 life is 20hr for fenofibrate , 1.5hr for gemfibrozil. 
- Absorbtion is enhanced in the presence of food. 
- Fenofibrate is more effective than gemfibrozil. 
Uses:       
- hyper TAG 
- Type 3 (dysbetalipoproteinemia) 
- Type 4 (hypertriglyceridemia) ĹVLDL. 
- Type 5 (elevated VLDL+chylomicrons) 
Adverse effect: 
- GIT: gastrointestinal upset. 
- Myopathy: more common in alcholics. 
- Inflammation of the muscles with Ĺcreatine level. 
- Lithiases: increase in gallstone incidence and gallbladder diseases. 
- This was a problem seen with clofibrate more than other fibrates . that is why it has 
been removed from the market. 
Drug interaction:   
- increase oral anticoagulant (warfarin) activity. 
- Fibrates Ĺ coagulation, so dose must be reduced when given with  
anticoagulant. 
- Aminotransferase elevation: drug must be stopped . 
- Arrhythmias. 
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Contraindications: 
- Hepatic\renal disease. 
- Billiary tract disease. 
- Combination with statins. 
2.  Bile-Acid binding (resin) 
- Colestipol(colestid). 
- Cholestyramine (Questran, Questran light). 
- Colesevelam (welcohol). 
Chemistry: 
- Polymeric cationic exchange resins. 
Pharmacokinetics: 
- Insoluble in water. 
- Not absorbed systemically, not metabolized. 
- Excreted unchanged in feces. 
Mechanism of action:  
- Bind bile acid in the intestine , so prevent their reabsorbtion. 
- Increased bile acid clearance causes increased conversion of cholesterol to bile 
acids. 
- Increase the uptake of plasma LDL by the liver (up regulation of LDL 
receptors). 
- Resins have NO effect on patients with homozygous familial hyperlipiemia. 
Clinical uses: 
- Type 2a (familial hypercholesterolemia). 
- Type2b (combined hyperlipidemia). 
- VLDL may increase so niacin for example is given to reverse this. 
- Pruritis: is incomplete biliary obstruction (cholestasis and bile salt 
accumulation). 
- Sever digitalis toxicity ( by Ļing their absorbtion). 
 
 
  
Department of Pharmacology                12          J.K.K. Nattraja College Of  Pharmacy   
 
 
Adverse effect: 
1. Constipation, bloating (psyilium seed). 
2. reduced absorption of drugs ( warfarin, digitalis glycosides, thiazides ,statins, iron 
salts ) . (Thus give it 1hr before or 4-6 hrs after) 
3. Interfere with absorption of fat soluble vitamins. 
4. Increase serum triglyceride (VLDL) 
 
3. HMG-CoA reductase inhibitors (statins) 
Chemistry: 
- Structural analogs of HMG-CoA  
- (3_hydroxy_3_methyl glutaryl_coenzyme A) 
Drugs: 
- Rosuvastatin (most imp) 
- Atorvastatin 
- Simvastatin 
- Pravastatin 
- Lovastatin 
- Fluvastatin (least imp) 
 
Mechanism of action:  
- Reversible competitive inhibition of HMG-CoA reductase . 
- Inhibit denovo synthesis of cholesterol. 
- Up regulation LDL high affinity receptors. 
- Small decrease in plasma triglycerides , slight increase in HDL cholesterol. 
 
Pharmacokinetics: 
- Prodrugs (lovastatin & simvastatin –GIT) 
 
- Active drugs: 
Atorvastatin – Pravastatin – Fluvastatin –Rosuvastatin. 
- All are given orally at night. 
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- All have high first pass effect. 
- Excreted mainly in bile. 
- 5-20 % is excreted in the urine. 
- T½ = 1-3 hrs except Atrovastatin (14 hrs), Rosuvastatin (19 hrs). 
- Food enhances absorption except Provastatin. 
 
Clinical uses: 
- Treatment of elevated LDL plasma levels: monotherapy or with bile-acid 
binding resins or ezetimibe or niacin. 
 
Adverse effect: 
- Aminotransferase elevation. 
- Myopathy (increase in creatine kinase, muscle pain) ĺ medication should be 
stopped. 
- Consequence of myopathy: myoglobinuria & acute renal failure ARF 
(Rhabdomyolysis). 
- Increase warfarin blood level. 
 
Contraindications 
- Female ĺ pregnant or lactating. 
- Children. 
- Severe liver disease. 
- Severe kidney disease. 
- Combination with cycbsporine – fibrates - azole & itraconazole (antifungal 
drugs) – erythromycin ĺ (precipitate myositis). 
Drug Interactions: 
- Simvastatin – lovastatin – atorvastatin one metabolize by CYT P450 3A4. 
- Flovastatin – Rosuvastatin one metabolize by CYT P450 2Ca. 
- Provastatin by sulfation (drug of choice ) 
- Erythromycin – ketoconazole – cimatidine – cyclosporine. 
- Rifampicine – phenytoin - phenobarbitone  
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4.  Niacin: 
 
- water soluble vitamin (B3) 
Pharmacokinetics: 
- given orally (2-3 gm/day in divided dose up to 6 gm) 
- excreted with urine. 
- Given with meals (because it irritates gastrointestinal mucosa). 
 
Mechanism Of Action: (figure) 
- Inhibits lipolysis in adipose tissue (due to intracellular lipoprotein lipase 
inhibition). 
-    TG synthesis  in the liver. 
- VLDL secretion. 
- Decrease VLDL and LDL plasma levels. 
- Increase HDL cholestrol in plasma. 
 
Clinical Uses: 
- familial hyperlipidemia. 
- Heterogenous familial hypercholestrolemia ( + resin /statins) 
- Most effective in increasing HDL cholesterol. 
Adverse effects: 
- Cutanuous flushing + warm sensation  
  (asprin pretreatment {30 min. before dosing } or lbuprofinal) 
- GIT disturbance  
- hyperuricemia + gout (allopurinol) 
- impaired glucose tolerance  
- Aminotransferase elevation 
- arrhythmia  
- hypotension ( potentiate the effect of antihypertensive ) 
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Contraindications:  
- sever peptic ulcers 
- diabetic ( if insulin resistance is increased ) 
 
5. Cholesterol absorption inhibitors                                                     
((Ezetimibe)) 
- inhibits intestinal absorption of dietary and biliary cholesterol in small 
intestine  
- decrease hepatic cholesterol stores  
- increase clearance of cholesterol from the blood  
- Reduce LDL level   
- metabolized in liver (phase 2 , active glucouronide )  
- long plasma half life 22hrs. (enterohepatic circulation ) 
- no effects on fat soluble vit. 
- excreted mainly in feces ( 80 %) 
- Daily dose of 10 mg/kg 
- synergestic action with statins   
- Plasma level: (see table of effects on LDL ,HDL,TG)  
- Increased (fibrates) 
- reduced (cholestyramin  ) 
- not affected by digoxin or  warfarin  
Drug combination 
Ezetinibe + statins  
- Treatment for hypercholesterolemia  
Niacin + statins  
- Treatment for familial combined hyperlipidemia  
Niacin + rosins  
- Treatment of familial combined hyperlipidemia  
- Familial hypercholesterolemia  
(niacin and fibronates are contraindicated by one another) 
Resins + statins 
- Treatment for familial hypercholesterolemia 
 
  
Department of Pharmacology                16          J.K.K. Nattraja College Of  Pharmacy   
 
 
Resins + fibrates  
- Treatment for familial combined hyperlipidemia  
- Increased risk of choliothiasis.  
Managing patients with Hyperlipidemia The current National cholesterol 
education programme (NCEP) guidelines for management of patients are of two 
types. One is a population-based approach to reduce CHD risk, which includes 
recommendations to increase exercise and to lower blood cholesterol by dietary 
recommendations. Use of complex carbohydrates and fiber is recommended. The 
second is the patient-based approach that focuses on lowering LDL levels as the 
primary goal of therapy [19] 
Need for Natural Hypolipidemic agents  
The use of statins in the treatment of Hyperlipidemia causes concern in both 
patients and physicians about the safety associated with such medications. Muscle 
toxicity or myopathy, is a common adverse effect of this class of drugs. Myopathy 
progressing to rhabdomyolysis and renal failure is the most serious side effect 
associated with all statins either in monotherapy or in combination therapy and 
appears to be doserelated. As statins therapy is for a long term basis, there may be a 
risk of chronic toxic effects like carcinogenic, teratogenic and mutagenic over a life 
time of use. Till date, there are very less natural medications available in the market to 
treat hyperlipidemia. Therefore it is a need of the day to search for natural 
medicaments because of their fewer side effects and less expensive as compared with 
synthetic drugs. So, numerous studies are needed to explore the anti-hyperlipidemic 
activity of herbs. This may, at least in part, help future studies to screen the newer 
anti-hyperlipidemic molecules. 
Antihyperlipidemic Drugs 
 Lipids are transported in the blood by being incorporated within lipoproteins. 
Lipoproteins are macromolecular disc like complexes of lipids and specific proteins 
called apoproteins. These apoproteins are crucial in the regulation of lipoprotein 
metabolism (they act as enzymes, cofactors or cell receptor ligands). Distinct classes 
of lipoproteins are found depending on the variation in lipid and apoprotein 
composition. Chylomicrons and their remnant contain apoprotein ß48 which is 
formed in the intestine. Apoprotein ß100 is synthesized in the liver and are found in 
(VLDL, IDL, LDL and lipoprotein a) Lipoproteins that convey lipids into the artery 
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wall. Plasma cholesterol and triglyceride are clinically important because they are 
major treatable risk factors for atherosclerosis and cardiovascular diseases. 
Hypertriglyceridemia also predispose to acute pancreatitis. ANTIHyperlipidemiC 
DRUGS Lipids are transported in the blood by being incorporated within lipoproteins. 
Lipoproteins are macromolecular disc like complexes of lipids and specific proteins 
called apoproteins. These apoproteins are crucial in the regulation of lipoprotein 
metabolism (they act as enzymes, cofactors or cell receptor ligands). Distinct classes 
of lipoproteins are found depending on the variation in lipid and apoprotein 
composition. Chylomicrons and their remnant contain apoprotein ß48 which is 
formed in the intestine. Apoprotein ß100 is synthesized in the liver and are found in 
(VLDL, IDL, LDL and lipoprotein a) Lipoproteins that convey lipids into the artery 
wall. Plasma cholesterol and triglyceride are clinically important because they are 
major treatable risk factors for atherosclerosis and cardiovascular diseases. 
Hypertriglyceridemia also predispose to acute pancreatitis. 
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Fig 1. Control of Hyperlipidemia 
 
From over a century, the allopathic industry has been trying to combat 
degenerative diseases like cardiovascular, metabolic syndromes, cancer, inflammatory 
disorders, neuro degenerative diseases such as Alzheimer’s, Parkinson’s, Hodgkin’s 
and other diseases. Though many advances in the diagnosis of diseases have been 
made, the battle to increase quality of human life and proper treatment of these 
diseases is still unmet. Till now there is no accurate therapy for many of these 
diseases without considerable adverse or serious side effects. At present, the only 
option is a long list of prescription drugs that may alleviate symptoms but slowly eat 
away body’s immunity and quality of life. Hyperlipidemia is one of the greatest risk 
factors contributing to prevalence and severity of cardiovascular complications like 
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coronary heart diseases including atherosclerosis. Hyperlipidemia is characterized by 
elevated serum total cholesterol and low density and very low density lipoprotein 
cholesterol and decreased high density lipoprotein. Hyperlipidemia associated lipid 
disorders are considered to cause the atherosclerotic cardiovascular complications. 
Among these hypercholesterolemia and hypertriglyceridemia are closely related to 
ischemic heart disease. High plasma level of cholesterol along with generation of 
reactive oxygen species (ROS) play key role in the development of coronary artery 
diseases (CAD) and atherosclerosis. Oxidative stress is currently suggested a 
mechanism underlying hypercholesterolemia 
Epidemiologic data reported that around 12 million people die of 
cardiovascular diseases and cerebral poplexy each year all over world. Therefore, it is 
very important to pay attention to early stage prevention and control of 
hyperlipidemia in a comprehensive way. The generally suggested measure for the 
treatment of hyperlipidemia associated diseases is through restriction of caloric intake 
or increased caloric expenditure and/or use of lipid lowering drugs. Many allopathic 
anti-hyperlipidemic drugs are available in the market but the side effects like 
hyperuricemia, diarrhea, myositis, hepatotoxicity, etc. were reported. Although statins 
were found to be effective in the lowering of serum low-density lipoprotein (LDL) as 
well as cholesterol level, they have been found to cause many side effects [8]. As they 
are basically enzyme inhibitors, so it is likely that they may be inhibiting other critical 
enzymes in the body. Moreover, statins are ingested on a long term, so there may be a 
risk of chronic toxic effects such as carcinogenicity, teratogenicity and mutagenicity 
over a life time of use [9].  
Therefore attention is now paid to search natural hypolipidemic agents from 
plant sources. India, having a rich tradition of folk medicine from centuries, has 
provided very simple but effective remedies to various ailments using plants and plant 
derived compounds. Ancient literature mentions many herbal medicines for treating 
various diseases like Diabetes mellitus, rheumatoid arthritis and cardiovascular 
diseases. We have also seen an increase in the popularity and use of natural remedies 
in developed countries, including herbs, herbal medicines, over-the-counter health 
foods, nutraceuticals and herbal medicinal products. The use of herbal medicines is 
especially prevalent in primary health care and for many chronic diseases. But 
unfortunately many potential plants in India lack scientific documentation. Chemical 
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principles from natural sources have become much simpler and have contributed 
significantly to the development of new drugs from medicinal plants. The valuable 
medicinal properties of different plants are due to presence of several constituents i.e. 
saponins, tannins, alkaloids, phenols, flavonoids, terpenoids etc . The numerous 
beneficial effects attributed to phenolic products have given rise to a new interest in 
finding botanical species with high phenolic content and relevant biological activity. 
The phenolic compounds provide hypolipidemic effect without restricting caloric 
intake and change in life style. But the amount of polyphenols present in our 
commonly consumed food is very low. Hence dietary supplements rich in 
polyphenols are recommended for achieving beneficial results.  
Evidences on the cholesterol-lowering properties of medicinal plants have 
been accumulating and a number of plants have been found to be useful in treatment 
of hyperlipidemia such as Allium sativum, Commiphora mukul, Boswellia serrata, 
Emblica officinalis, Garcinia cambogia, Terminalia arjuna, Trigonella foenum-
graecum, Ocimum sanctum, Withania somnifera and Zingiber officinale. The present 
study was aimed to evaluate the selected herbal drugs for their usefulness in the 
lowering of cholesterol levels and treating cardiovascular complications. Plant 
selection was done based on the active chemical constituents such as phenols and 
flavanoids present in them and their antioxidant potential. The selected plants were 
first screened for their antioxidant activity by using different in-vitro methods. After 4 
confirming the antioxidant potential of the extracts. 
Elaeocarpus is a genus belonging to family Elaeocarpaceae contain tropical 
and subtropical evergreen trees and shrubs. It is widely distributed from Madagascar 
in the west through India, Southeast Asia, Malaysia, Southern China, and Japan, 
through Australia to New Zealand, Fiji, and Hawaii in the east with its approximately 
350 species. The islands of Borneo and New Guinea have the greatest concentration 
of species1. Some common species with their Occurrence are as follows: 
Elaeocarpus aberrans New Guinea 
Elaeocarpus acuminatus India. Endangered. 
Elaeocarpus amoenus Sri Lanka 
Elaeocarpus angustifolius Queensland, Australia. 
Elaeocarpus apiculatus China, Indonesia, Malaysia, Philippines 
Elaeocarpus blascoi India. Endangered. 
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Elaeocarpus coorangooloo Queensland (Australia) 
Elaeocarpus coriaceus Sri Lanka 
Elaeocarpus crassus New Guinea 
Elaeocarpus dentatus New Guinea 
Elaeocarpus eumundii Australia 
Elaeocarpus ganitrus (rudraksh tree) India, South-East Asia, Indonesia, New Guinea, 
Australia, Guam, and Hawaii 
Elaeocarpus gaussenii Southern India. Endangered. 
Elaeocarpus grandiflorus India, Indo-China, Malesia 
Elaeocarpus hartleyi New Guinea 
Elaeocarpus hedyosmus Sri Lanka 
Elaeocarpus hookerianus Pokaka. New Zealand. 
Elaeocarpus holopetalus New South Wales, Victoria (Australia) 
Elaeocarpus williumsianus NSW, Australia 
Elaeocarpus variabilis Southern India 
Elaeocarpus timikensis New guinea 
Elaeocarpus taprobanicus Sri lanka 
Elaeocarpus sylvestris Japan, Taiwan, China, Indochina 
Elaeocarpus stipularis Indochina, malasia 
Elaeocarpus sikkimensis India, Bhutan 
Elaeocarpus serratus South asia 
Elaeocarpus robustus India, Bangladesh 
Elaeocarpus obovatus Australia 
Elaeocarpus neobritannicus New Guinea 
Elaeocarpus photiniaefolius Ogasawara island 
Elaeocarpus montanus Sri lanka 
Elaeocarpus miegei New Guinea 
Elaeocarpus lanceifolius South Asia 
Elaeocarpus kirtonii Australia 
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2. LITERATURE REVIEW 
 
The comprehensive review of literature is an essential part of any scientific 
investigation, its main functions are to determine the previous work done, assist in 
delineation of problem area, provide basis for theoretical framework, and provide an 
insight into methods and procedures to be used, suggest operational definitions of 
major concepts and to help for interpretation of findings. Review of literature is 
directly or indirectly relevant to the objectives of the study. 
 
Singh and Mehta, (1977) reported that Shankhpushpi (C. pluricaulis) possessed 
significant beneficial effects in patients of anxiety neurosis.  
Gupta, et al, (1981) studied the effect of C pluricaulis in patients of thyrotoxicosis 
and reported that it was more effective with fewer side effects when compared with 
Diazepam and Neomercazole. 
Shukla, (1981) reported that the C pluricaulis had anti-anxiety effect and also it 
showed reduced plasma cortisol and urinary catecholamines levels. 
 Dash, et al, (1983) reported that decoction of C pluricaulis showed psychotropic 
activity in human adults when given orally (50 ml). 
Parikh, et al, (1984) studied efficacy of ‘Gko 22’ containing C microphyllus, 
Hydrocotylasiatica, Withaniasomnifera, Glycyrrhizaglabra, Saussurealappa, 
Acoruscalamus, Rauwolfiaserpentina, Myristicafragrans in 17 refractory cases and 22 
untreated cases of Schizophrenia. About 50% of patients in both groups showed more 
than 50% improvement without any prominent side effects after 6 weeks of treatment.  
Vaidya and Kulkami, et al. (1991 ) studied the Ayurvedic formulation ‘Jivak’ with 
Shankhpushpi as one of the ingredients. Improvement in appetite, increase in weight 
and feeling of freshness were observed in treated patients. 
Pandit, et al, (1992) used the herbal formulation ‘Thyrocap’ containing Convolvulus 
pluricaulis for the treatment of different types of goiter. The treatment showed marked 
symptomatic as well as biochemical improvement in patients of simple diffuse goiter.  
Dandekar, et al, (1992) showed that antiepiletic activity of phenytoin was reduced 
and there was loss of seizure control following the administration of an ayurvedic 
preparation containing Shankhpushpi, which could be attributed to pharmacodynamic 
or pharmacokinetic interaction of drug with phenytion. 
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Kushwaha and Sharma, (1992) reported the potent anti-depressant activity of 
Shankhpushpi syrup in patients with depressive illness. 
Rajagopalan, (1995) studied the formulation ‘Ayushaman-8’ containing C 
pluricaulis, C asiatica, and A calamus. It showed improvement in attention activity 
level, feed back and in controlling the hyperactivity, aggressiveness etc. in mentally 
retarded children. 
Simonson, (1995) was studied data from several epidemiological expressed that the 
prevalence of hypertension in patients with DM  from 5 to 20 times greater than non 
diabetic population and associated types-I DM with hypertension not able to find at 
the time of diagnosis due to renal insufficiency, increase blood pressure which may 
exacerbate the progression to end-stage renal failure. The incidence of hypertension 
with DM has related to degree of obesity, increased age and extensive atherosclerosis 
and it probably includes many patients with essential hypertension. Several other 
pathophysiological mechanism contribute the genesis and maintenance of 
hypertension associated with DM. 
 International Diabetes Mellitus Federation, (2003) was expressed, guide, we have 
examined and discussed the variety of guidelines already developed in the field of 
diabetes, and the accessible information on development and implementation of high-
quality clinical practice guidelines, both within the diabetes world and elsewhere. 
This Guide has been prepared for the IDF Clinical Guidelines Task Force at the 
request of the IDF Executive Board. 
Rajappan, et al, (2004) have helps to monitored by communicable diseases 
surveillance in Kottayam district, Kerala state, India and also 100 diseases are reports 
for every month. The most frequently reported diseases were acute dysentery, 
leptospirosis, typhoid and hepatitis.  The usage of vaccines for communicable 
diseases such as childhood diseases, measles diphtheria, tetanus and whooping cough 
were reported. In this conclusion various communicable diseases occurrence were 
detected quickly to identify the various diseases and highly successful to take control 
measures. 
Colin Mathers and DejanLoncar, (2005) have expressed updated projections of 
global mortality from 2002-2030 to burden of diseases which includes data sources, 
methods and results Non-overweight death rates are reduced at 74% of rate for Other 
Group II deaths non-overweight death rates reduction at 51% of rate for Other Group 
  
Department of Pharmacology                24          J.K.K. Nattraja College Of  Pharmacy   
 
 
II deaths non-overweight death rates declining at 100% of rate for Other Group II 
deaths. 
Mohan, et al, (2007), have been explained anti diabetic drugs produced age variation 
based to change of onset of DM to a younger age the recent years and also lasting 
adverse effects on nation’s health and economy. They are identified early risk of 
individuals using easy screening tools to evaluate Indian Diabetes Risk Score (IDRS) 
and appropriate lifestyle intervention would greatly helps to preventing or postponing 
the onset of diabetes to community and the nation as a whole. 
Hussain et al., (2011) and observed the presence of tannins, steroids, flavonoids, 
glycosides, saponin, alkaloids, proteins, amino acids and acidic compounds. 
Gunjan et al., (2010) has made a review of pharmacognonstical study of Coccinia 
indica and opined that fruit extract has significant anti diabetic properties. 
Pharmacognonstical studies of Coccinia indica done  
Sutar et al., (2010) and they detected the alkaloids, carbohydrates, glycosides, 
flavonoids, tannins and saponins. 
Khatun et al., (2012) has studied phytochemical screening and antimicrobial activity 
of Coccinia cordifolia and noticed the presence of compounds like flavonoids, 
saponins, tannins and terpenoids. The plant shows activity against Shigella 
dysenteriae, Escherichia coli and Staphylococcus aureus. 
Mahmood et al., (2012) and noticed that aqueous seed extract shows antimicrobial 
activity against Pseudomonas multocida, Salmonella typhi and L. bulgaricus and 
ethanol seed extract showed significant antimicrobial activity against S. aureus, M. 
luteus, E. coli and S. epidermidis and L. bullgaricus and petroleum ether extract were 
effective against 
Vasantha et al., (2012) and detected presence of flavonoids and steroids in leaf 
extract. The flavonoids, tannins, triterpenoids, phenols, steroids, glycosides and 
cardiac glycosides was detected in the chloroform, methanol and acetone extract but 
saponin was detected only in methanol and acetone extract. 
Experimental studies of anti-hepatotoxic effect of Trichosanthes tricuspidata by 
Vidyasagar (2012) revealed the presence of carbohydrates, proteins, alkaloids, 
glycosides and flavonoids which shows anti-hepatotoxic effect. In physico-chemical 
analysis they noticed that drugs were free of impurities like silica, carbonates, 
phosphates etc. 
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Poovendran et al., (2011) has performed the antimicrobial assay of Coccinia grandis 
against E. coli and noticed that ethanol extract exhibit maximum activity whereas 
aqueous leaf extract and acetone extract does not show any antimicrobial activity. 
Dhiman et al., (2012) has enumerated some important plants of the family 
Cucurbitaceae plants are: Momardica charantia, Cucurbita pepo, Cucurbita 
andreana, Cucurbita ficifolia, Cucumis sativus, Cucumis melo, Citrullus colocynthis, 
Luffa echinata, Trichosanthes kirilowili, Lagenaria siceraria, Benicasa hispida etc. 
Tamilselvan et al., (2011)  noticed that presence of steroids in petroleum leaf extract 
and detected the compounds like tannins, glycoside, proteins, amino acid, saponins 
and alkaloids in studied extracts. 
Sivaraj et al.,(2011) against some selected bacterial spp. and concluded that the 
ethanolic leaf extract exhibits maximum activity against S. aureus, B. cereus, E. coli, 
E .pneumonia and S. pyrogens. 
Arawwawala et al., (2011) has noticed antibacterial activity of Trichosanthes 
cucumerina in hot water extract and cold ethanolic extract against Staphylococcus 
aureus, Streptococcus pyrogenes, Escherichia coli and Pseudomonas aeruginosa and 
observed that water extract showed significant activity against S. aureus, S. 
pyrogenes, E. coli, P. aeruginosa. The cold water extract has higher antibacterial 
activity than the hot water extract. 
Gopalakrishnan et al., (2012) has performed antimicrobial activity of Cucumis 
trigonus fruits and observed that the petroleum ether and chloroform extracts does not 
show any activity while the ethanolic extract showed more activity than the benzene 
and aqueous extracts against Candida albicans, Aspergillus flavans, Klebsiella 
aeruginosa, Pseudomonas aeruginosa and Bacillus subtilis. 
Bhattacharya et al., (2010) has evaluated antifungal and antibacterial activity of 
Coccinia grandis and observed that the antifungal activity  on Candida albicans and 
Aspergillus niger and antibacterial activity was observed on gram positive bacteria 
like Bacillus subtilis, Staphylococcus aureus, Escherichia coli and Salmonella typhi.  
Ashwini et al., (2012) and noticed that the ethanol and methanol extract has 
significant antioxidant property. Antimicrobial activity and phytochemical screening 
of the fruit extracts of Coccinia indica was evaluated . 
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Syed et al., (2009) and reveals that the presence of phytochemicals like alkaloid, 
steroid, tannins, saponins, phenols, glycosides, and triterpenoids. Petroleum ether 
extract was the most active and showed considerable antibacterial activity against all 
tested gram positive and gram negative bacteria. Least activity was in chloroform 
extract.  
Khare  et al (2007) noticed that Trichosanthes tricuspidata contain Cucurbitacins, it 
possess anti-tumor, anti-inflammatory, anti- asthmatic, anti-fertility, anti-microbial 
and anti-hermitic properties.  
Shah et al., (2010). The phytochemical study shows bitter fruit contains cucurbitacins 
B, D, G and H. The leaves contain cucurbitacins B, D, and traces of E. fruit having 
anti hyperlipidemic, analgesic and anti-inflammatory, diuretic, antioxidant activity. 
Deore et al., (2009) were studied in vitro antioxidant activity and quantitative 
estimation of phenolic content of Lagenaria siceraria. Phytochemical screening of the 
crude ethanolic extract of fruit revealed the presence of flavonoids, saponins, 
glycosides and phenolic compounds which bears antioxidant activity. 
Erasto et al., (2009) made HPTLC profile of Lagenaria siceraria fruits and noticed 
that it has high DPPH radical scavenging effect at all concentrations. The ethyl acetate 
extract shows more activity more activity than rest of the samples. 
Pawar et al., (2009) were evaluated central nervous system activity of different leaf 
extracts of Lagenaria siceraria. In their study, three extracts of leaves, petroleum 
ether, chloroform and methanol were used to study the CNS depressant activity in 
several animal models. In phytochemical screening the flavonoids, steroid, alkaloid, 
tannin, and saponin were detected. 
Chinyere et al., (2009) The antibacterial activities of Coccinia grandis was evaluated 
and noticed that water extract of leaves and ethanol extract of stem showed high 
activity against Shigella boydi and Pseudomonas aeruginosa respectively. 
Tomori et al., (2007) were evaluated the antibacterial activity of ethanolic fruit extract 
of Lagenaria breviflora. Tang et al., (2010) observed antimicrobial activity of 
sphingolipids isolated from stems of Cucumber (Cucumis sativus). The change in 
mineral contents in fruit occurs due to infection of rot fungal pathogens in ivy gourd 
(Coccinia indica) which results in reducing the nutritional value. 
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Modgil et al., (2004) were determined carbohydrate and mineral content of Chyton 
(Sechium edule) and Lagenaria siceraria. Both plants were analyzed for their 
carbohydrate content viz, crude fiber, reducing sugar, non-reducing sugar and 
different dietary fiber constituents like NDE, ADF, legine, Cellulose and 
hemicelluloses and minerals. 
Hossain et al., (2012) were evaluated anti-inflammatory activity and determination of 
total flavonoids and tannin contents of Lagenaria siceraria root. The phytochemical 
screening and antimicrobial activity of Cucurbita pepo was carried out. 
Dewanjee et al., (2007) has studied antimicrobial activity of crude extract from 
Coccinia grandis and noticed that they are active against selected micro-organisms. 
Bajpai et al., (2012) has performed HPTLC of Cucurbita maxima seed and observed 
that the presence of steroids, carbohydrates, unsaturated fatty acids and saturated fatty 
acids in the seed extract.  
Chand et al., (2012) noticed the presence of alkaloids, proteins, carbohydrates, 
flavonoids, glycosides, saponins and tannins in alcohol and water extracts. The 
nutritive and medicinal property of Cucurbits were recorded and observed that the 
cultivated cucurbits are the good sources of vitamins and minerals. 
Kirtikar et al., (1987) reported that Diplocyclos palmatus was distributed throughout 
India, the annual climber with bright red fruit have high medicinal value. 
Gupta et al., (2014) has studied phytochemistry, pharmacology and folklore use of 
Diplocyclos palmatus and noticed the presence of alkaloids, flavonoids, tritrpenoids, 
saponins, steroids, proteins and resins. The plant has anti-inflammatory properties. 
Saboo et al., (2013) were evaluated phytochemical detection and anticancer potential 
of chloroform root extract of Trichosanthes tricuspidata. 
Deshpande et al., (2008) were evaluated the ethanolic fruit extract of Lagenaria 
siceraria against the disorders where free radicals play a major role in pathogenesis. 
The above review reveals that the selected medicinal plants have attracted the 
attention of workers of pharmacognosy for quite long time. Many investigations in the 
diverse disciplines have also been undertaken. Pharmacognosy and phytochemistry 
has also been studied in large measure. But the ethno medicinal uses with 
Phytochemical. 
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3. AIM & OBJECTIVE 
 
Productively assess the antihyperlipidemic and antioxidant activity of Elaeocarpus  
leaf extract on elevated fat diet-induced hypercholesterolemia & triton induced 
hyperlipidaemia models. 
1. Collection of literature survey for set up the significance of the study. 
2. authenticate of Elaeocarpus  with the help of botanist. 
3.  Extract the dried leaf of Elaeocarpus  using suitable solvents. 
4. Invivo Model  
a. Diet induced 
b.Triton induced hyperlipidemia 
.  
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4. PLANT PROFILE 
Elaeocarpus is a genus of tropical and subtropical evergreen trees and shrubs. The 
approximately 350 species are distributed from Madagascar in the west 
through India, Southeast Asia, southern China, and Japan, through Australia to New 
Zealand, Fiji, and Hawaii in the east. The islands of Borneo and New Guinea have the 
greatest concentration of species. These trees are well-known for their attractive, 
pearl-like fruit which are often colorful. A notable feature of the family is the 
drooping, often frilly, small clusters of flower. Many species are threatened, in 
particular by habitat loss. 
In Darjeeling and Sikkim areas, the fruit of several species of Elaeocarpus is 
called bhadrasey and is used to make pickles and chutney. The seeds of Elaeocarpus 
ganitrus are used to make rudraksha, a type of Hindu prayer beads. 
South Indian Marble Tree is a tree up to 20 m tall. Bark is brownish, warty, wood 
white to cream. Branchlets are round with fallen leaf scars, warty. Leaves are simple, 
alternate, spiral, clustered at twig ends. Leaf-stalk is 3 cm long, planoconvex in cross 
section, purple. Leaves are up to 8 × 5 cm, broad elliptic to elliptic-oblong, tip long-
pointed, base narrow, margin toothed, somewhat leathery, hairless, red when young. 
Midrib and nerves purple; secondary nerves about 7 pairs, forked with glabrous 
domatia at axils beneath. Flowers are borne in racemes in leaf axils, with purple 
branches, up to 15 cm long. Flower-stalks are 1 cm long, purple. Flowers are white 
with frilly petals. Anthers are neither bearded and nor awned. Fruit is ellipsoid, 4 × 3 
cm, 1-seeded. South Indian Marble Tree is endemic to the Western Ghats - occasional  
Botanical name: Elaeocarpus variabilis 
Family: Elaeocarpaceae 
Synonmys: Elaeocarpus glandulosus, Elaeocarpus oblongus 
Common name: South Indian Marble Tree, Jew's plum  
Kannada: bike, bikki, hanaltadi, hanillatade, hennalalade  
Malayalam: kattakara, malamkara, malankara  
Marathi: kasa  
Tamil: malankarai  
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Fig 4. Elaeocarpus variabilis leaf 
 
 
 
 
 
 
Fig 5. Elaeocarpus variabilis whole plant-I 
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Fig 6. Elaeocarpus variabilis whole plant-II 
 
 
 
 
 
Fig 7. Elaeocarpus variabilis whole plant-III 
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Fig 8. Elaeocarpus variabilis whole plant-IV 
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5. MATERIALS AND METHODS 
a) Plant collection 
The flower part of plant was collected from less rain fall irrigation hills and 
which authenticated by recognized plant survey office. 
b) Extraction procedure by Cold maceration 
The 1000g of coarse powder of plants, mixed with 2000ml of solvent in round 
bottom flask, which  kept for 15days and shaken regularly 2 times per day and 
decanted. The extracts are dried under reduced pressure and stored in a desiccator. 
d)  Preliminary Phytochemical screening 
1. Test for Carbohydrate 
Molisch’s test 
To 2-3 ml of extract, added few drops of α-naphthol solution in alcohol, shake 
and added concentrated H2SO4 from sides of the test tube to form violet ring at the 
junction of two liquids. 
Benedict's test – Test solution was mixed with few drops of Benedict's reagent 
(alkaline solution containing cupric citrate complex) and boiled in water bath.  
2. Test for Proteins 
Biuret Test – Test solution was treated with 10% sodium hydroxide solution 
and two drops of 0.1% copper sulphate solution and observed for the formation of 
violet/pink color. 
3. Test for Free Amino Acids 
Ninhydrin Test – Test solution when boiled with 0.2%solution of Ninhydrin, 
would result in the formation of purple color. 
.4. Test for Steroids and Triterpenoids 
Liebermann Burchard test - Crude extract was mixed with few drops of acetic 
anhydride, boiled and cooled. Concentrated sulphuric acid was then added from the 
sides of the test tube and observed for the formation of a brown ring at the junction of 
two layers.  
5. Test for Glycosides: 
Keller Killiani Test – Test solution was treated with few drops of glacial acetic 
acid and Ferric chloride solution and mixed. Concentrated sulphuric acid was added, 
andobserved for the formation of two layers.  
  
Department of Pharmacology                34          J.K.K. Nattraja College Of  Pharmacy   
 
 
Bromine water test - Test solution was dissolved in bromine water and observed for 
the formation of yellow precipitate to show a positive result for the presence of 
glycosides. 
6. Test for Saponins: 
Foam Test – Test solution was mixed with water and shaken and observed for 
the formation of froth, which are stable for15 minutes for a positive result. 
7. Test for Alkaloids: 
Hager's Test – Test solution was treated with few drops of Hager's reagent 
(saturated picric acid solution). Formation of yellow precipitate.. 
8. Test for Flavonoids: 
a) Ferric chloride test: Test solution when treated with few drops of Ferric 
chloride solution would result in the formation of blackish red color. 
b) Alkaline Reagent Test: Extracts were treated with few drops of sodium 
hydroxide solution. Formation of intense yellow colour, which becomes colourless on 
addition of dilute acid.  
c) Lead acetate Test: Extracts were treated with few drops of lead acetate 
solution. Formation of yellow colour precipitate. 
d) Alkaline reagent Test: Test solution when treated with sodium hydroxide 
solution, shows increase in the intensity of yellow color which would become 
colorless on addition of few drops of dilute Hydrochloric acid, acetate solution Test – 
Test solution when treated with few drops of lead acetate (10%) solution.  
2.5 Animals: Wistar rats ranges from 150 – 180 gms & Sprague–Dawley rats 
weighing 200- 250 gms, of either sex were obtained from Central animal house,-------
---------------------------------. Animals were maintained under standard laboratory 
conditions at an ambient temperature of 25°C. Animals had free access to food and 
water with a natural light and dark cycle. Animals were acclimatized for at least 5 
days before behavioral experiments. The study protocol was approved by Institutional 
Animal Ethics Committee (IAEC) of the college and the experiments were carried out 
as per CPCSEA guidelines No:------------------------------------------ 
Groups: 
 Group I – Control (Normal saline 1 ml/kg), 
 Group II – Standard (Imipramine 15 mg/kg),  
Group III –  EEHC 200 mg/kg ,  
Group IV – EEHC 400 mg/kg, Group  
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High Cholesterol (HC)-Diet  
  Sprague–Dawley rats weighing 200- 250 gm, were divided into 4 groups of 6 
animals each. The animals of all the groups except normal group were given a lipid 
diet consisting of 2% cholesterol, 1% cholic acid and 2 ml coconut oil with standard 
pellet diet for 30 days. The first group (Normal control) received normal saline orally 
for 30 days. The second group (High cholesterol diet (HCD)- positive control) was 
given High cholesterol diet (HCD) while the third and fourth groups were treated with 
hydroalcoholic extract of EEHC(200 mg/kg and 400mg/kg, p.o.) respectively, once a 
day for 30 days. The fifth group was treated with Atorvastatin suspension prepared 
with 0.5% CMC (10mg/kg; p.o.), once a day for 30 days. After 30 days blood was 
collected by retro orbital sinus puncture, under mild ether anaesthesia. The collected 
samples were centrifuged for 10 minutes at 2000 r.p.m. and serum samples so 
collected were used for various biochemical tests The animals were then sacrificed 
and the liver collected. 
Triton Induced Rat Model 
Eight week old adult male albino rats of Wistar strain, weighing 
approximately 150 to 200 g, were acclimatized for 7 days at room temperature 
(22±2ºC) and humidity of 45-64% in a 12- hour light/dark cycle in a room under 
hygienic condition. They were given access to water and a commercial diet ad 
libitum. Intraperitoneal (i.p) injections of Triton WR-1339 at a dose of 400 mg/kg 
body weight. After 72 hours of triton injection received a daily dose of 5% CMC in 
5ml/kg body weight for 7 days . At the end of 8th day, rats were fasted overnight and 
sacrificed by cervical dislocation. Blood was collected, and serums were separated by 
centrifugation. Liver tissues were excised immediately and rinsed in ice-chilled 
normal saline, 500mg of the tissues were homogenized in 5.0 ml of 0.1 M Tris–HCl 
buffer (pH, 7.4). Biochemical estimations were carried out in serum and liver tissues, 
parameters such as cholesterol, phospholipids, triglycerides, LDL, VLDL and HDL 
were analyzed. 
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6. RESULT AND DISCUSSION 
 
Table. No:1: Ethanolic extract of Elaecarpus variabilis(EEHC) 
 
Class of  
compounds 
 
Tests performed 
 
Results  
 
Carbohydrates  
Molisch’s test 
Fehling’s test 
EEHC 
 
+ 
Phenols Phosphomolybdic acid test + 
Flavonoids Shinoda test 
Lead acetate test 
+ 
Alkaloids Wagner’s 
Mayer’s 
Draggendrof’s test 
+ 
Glycosides Legal’s test 
Brontranger’s test 
+ 
Saponins Foam test - 
Sterols Salkowski’s test + 
Amino acids Ninhydrin test + 
Terpenoids Lieberman Burchardt test + 
Gums and 
Mucilage 
Alcoholic precipitation - 
                     + =Present 
                     -  =Absent 
The phytochemical studies results revealed that the Molisch’s test no characteristic 
observation indicated the presence of carbohydrates in both extract. Green color 
formed indicated the presence of phenols in both extracts. Pink or red coloration of 
the solution indicated the presence of flavonoids in both. Orange coloration of the 
spot indicated the presence of alkaloids Yellow or reddish brown precipitation 
precipitation indicated the presence of alkaloids in both. Pink to red color solution 
indicates the presence of glycosides in both extract. No layer of foam formation 
indicates the absence of saponins in both extracts. Pink and red color observed 
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indicated presence steroids in both extract. Violet precipitation formed in the presence 
of amino acids in  both . Red coloration of the solution formation indicated the 
presence of terpenoids in both extracts. White color precipitation was not formed 
indicated the absence of gum and mucilage in both extracts.  
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Triton Induced Rat Model 
 
 
 
 
 
 
 
 
 
 
 
Groups Lipid profile in Serum 
Cholesterol Triglycerides HDL LDL VLDL Phospholipids 
Control 70.28±2.24 65.58±2.11 22.68±1.51 13.12±0.42 12.27±0.32 56±0.45 
Triton induced 157.73±2.62 125.58±2.11 25.45±1.24 113.18±3.19 25.12±0.42 66±0.58 
Ethanolic 
extract 
109.73±2.31 105.78±2.08 31.67±1.18  21.16±0.4 57±0.67 
Aqueous 
extract 
96.12±2.01 95.97±1.43 37.92±1.59 45.7±2.44## 19.19±0.29 53±1.62 
Standard 
(Atrovastatin) 
84.33±1.48 84.97±3.394## 40.7±1.12## 34.86±2.51## 16.99±0.68 49.2±0.45 
Groups Lipid profile in liver 
Cholesterol Triglycerides HDL LDL VLDL Phospholipids 
Control 62.28±2.24 55.58±2.11 21.68±1.51 13.12±0.42 12.27±0.32 46.2±0.45 
Triton induced 147.73±2.62 115.58±2.11 24.45±1.24 106.18±3.19 25.12±0.42 56.1±0.58 
Ethanolic 
extract 
99.73±2.31 97.8±2.08 30.67±1.18 73.14±2.1 21.16±0.4 47.2±0.67 
Aqueous 
extract 
86.12±2.01 95.97±1.43 36.92±1.59 35.7±2.4 19.19±0.29 43.3±1.62 
Standard 
(Atrovastatin) 
74.33±1.48 84.97±3.394## 39.7±1.1 44.86±2.5 16.99±0.68 39.2±0.45 
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Oral administration of hydroalcoholic extract doses (200 mg/kg and 
400mg/kg, p.o.) to Triton induced hyperlipidemic rats, significantly reduced the 
serum and liver cholesterol (TC), triglyceride (TG), low density lipoprotein-
cholesterol (LDL-C)  and VLDL-cholesterol levels. Levels of serum and liver HDL-
cholesterol were significantly increased in rats treated with has compared to Triton 
treated rats 
Estimation of serum total cholesterol was done at 15 & 24 hrs after induction 
of hyperlipidemia by Triton induced hyperlipidemic rats. At 15 hrs normal control 
rats had Mean ± SEM of serum cholesterol level was 70.28±2.24 and at 24 hrs 78.88 
± 4.10.Where the total cholesterol levels of rats treated with Oral administration of 
hydroalcoholic extract doses (200 mg/kg and 400mg/kg, p.o.) to Triton induced 
hyperlipidemic rats, significantly reduced the serum and liver cholesterol (TC), 
triglyceride (TG), low density lipoprotein-cholesterol (LDL-C)  and VLDL-
cholesterol levels. Levels of serum and liver HDL-cholesterol were significantly 
increased in rats treated with has compared to Triton treated rats 
Estimation of serum total cholesterol was done at 15 & 24 hrs after induction 
of hyperlipidemia by Triton induced hyperlipidemic rats. At 15 hrs normal control 
rats had Mean ± SEM of serum cholesterol level at 24 hrs 78.88 ± 4.10.Where the 
total cholesterol levels of rats treated with Triton induced rats had total cholesterol at 
15 & 24 hr. It Showed the significantly increases in total cholesterol levels in disease 
control. On 24 hrs total cholesterol level of rats treated with extract at the dose of 200 
mg/kg was 113.9 ± 2.73 Showed significantly decrease in total cholesterol levels as 
compared to disease control group. While in case of rats treated with of standard drug 
Atorvastatin Mean ± SEM was found to be 94.3±3.26 at 24 hrs. extract at the dose of 
400 mg/kg was Showed potent antihyperlipidemic activity as compared to other 
extracts. 
Serum HDL level at 15 hrs normal control rats had Mean ± SEM 24 hrs. 
where the HDL levels of the rats treated with Triton induced rats at 15 & 24 hrs were , 
Showed the significantly decreases in HDL levels in disease control. On 24 hrs HDL 
level of the rat treated with extractwhole plant extract at the dose of 400mg/kg were 
,Showed significantly increase in HDL levels as compared to disease control group. 
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While in case of rats treated with standard drug Atorvastatin Mean ± SEM was found 
to be 41.1±2.35at 24 hrs. 
LDL level at 15 hrs normal control rats had Mean ± SEM of at 24 hrs 24.32 ± 
5.01.where the LDL levels at 15 & 24 hrs. Showed the significantly increases in LDL 
levels in disease control. On 24 hrs LDL level of the rats treated with extract whole 
plant extract at the dose of 400mg/kg were 48.2±5.4,it Showed significantly decrease 
in LDL levels as compared to disease control group. While in case of rats treated with 
standard drug Atorvastatin Mean ± SEM was found to be 49.86±4.21 at 24hrs 
VLDL level at 15 hrs normal control rats had Mean ± SEM of was17.39 ±1.04 
and at 24 hrs 16.6 ± 0.89.where the VLDL levels of the rats treated with Triton 
induced rats at 15 & 24 hrs were 33.68± 1.40,35.88 ± 1.94, it Showed the 
significantly increases in VLDL levels in disease control. On 24 hrs VLDL level of 
rats treated with extract at the dose of 400mg/kg were 17.52±0.60 Showed 
significantly decreased in VLDL levels as compared to disease control group. While 
in case of rats treated with standard drug Atorvastatin Mean ± SEM was found to be 
23.5±0.62 at 24 hrs. All the results were shows statistical significant. 
The total cholesterol at 15 & 24 hrs were 171.2 ± 2.81, 177.6 ± 3.98. It 
Showed the significantly increases in total cholesterol levels in disease control. On 24 
hrs total cholesterol level of rats treated with extract at the dose of 200 mg/kg was 
113.9 ± 2.73 Showed significantly decrease in total cholesterol levels as compared to 
disease control group. While in case of rats treated with of standard drug Atorvastatin 
Mean ± SEM was found to be 94.3±3.26 at 24 hrs. extract at the dose of 600 mg/kg 
was Showed potent antihyperlipidemic activity as compared to other extracts. 
Serum HDL level at 15 hrs normal control rats had Mean ± SEM of was 37.7 
±2.39 and at 24 hrs 37.92 ± 2.29 where the HDL levels of the rats treated with Triton 
induced rats at 15 & 24 hrs were 28.62 ± 2.81, 25.7 ± 2.59, Showed the significantly 
decreases in HDL levels in disease control. On 24 hrs HDL level of the rat treated 
with Tephrosia purpurea whole plant extract at the dose of 600mg/kg were 41.7±3.08 
,Showed significantly increase in HDL levels as compared to disease control group. 
While in case of rats treated with standard drug Atorvastatin Mean ± SEM was found 
to be 41.1±2.35at 24 hrs. 
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LDL level at 15 hrs normal control rats had Mean ± SEM of was 25.5 ±5.23 and at 24 
hrs 24.32 ± 5.01.where the LDL levels at 15 & 24 hrs were 108.9 ± 5.48,116 ± 
6.4Showed the significantly increases in LDL levels in disease control. On 24 hrs 
LDL level of the rats treated with Tephrosia purpurea whole plant extract at the dose 
of 600mg/kg were 48.2±5.4,it Showed significantly decrease in LDL levels as 
compared to disease control group. While in case of rats treated with standard drug 
Atorvastatin Mean ± SEM was found to be 49.86±4.21 at 24hrs 
VLDL level at 15 hrs normal control rats had Mean ± SEM of was17.39 ±1.04 
and at 24 hrs 16.6 ± 0.89.where the VLDL levels of the rats treated with Triton 
induced rats at 15 & 24 hrs were 33.68± 1.40,35.88 ± 1.94, it Showed the 
significantly increases in VLDL levels in disease control. On 24 hrs VLDL level of 
rats treated with extract at the dose of 600mg/kg were 17.52±0.60 Showed 
significantly decreased in VLDL levels as compared to disease control group. While 
in case of rats treated with standard drug Atorvastatin Mean ± SEM was found to be 
23.5±0.62 at 24 hrs. All the results were shows statistical significant. 
High diet induced hyperlipidemia 
Sample Treatment (mg/dl) 
Serum Control HC HC+ 
Ethanolic 
Extract 
HC+ 
Aqueous 
Extract 
HC+ 
Standard 
(Atrovastatin) 
TC 142.6 ± 
2.0 
209.0 ± 9.0 169.86±0.98 155.3±0.94 146.6 ± 5.2 
TG 128.3 ± 
23.0 
215.0 ± 8.0 155.0 ± 7.5 132.9 ± 6.5 129.0 ± 7.0 
LDL 70.9±0.27 126.±0.63 97.05±0.82 84.51±0.37 74.59±0.56 
HDL 44.0 ± 2.4 36.8 ± 4.4b 37.6.0 ± 3.3 41.3±0.56 41.2±0.17 
Phospholipids 
 
56±0.45 66.1±0.58 57.2±0.67 63.3±1.62 47.2±0.57 
Oral administration of hydroalcoholic extract of (200 mg/kg and 400mg/kg, 
p.o.) significantly reduced the serum and liver cholesterol (TC), triglyceride (TG), 
low density lipoprotein-cholesterol (LDL-C) and VLDL-cholesterol levels  but 
significantly increased serum and liver HDL-cholesterol level as compared with high 
cholesterol diet (HCD) treated rats. 
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7. CONCLUSION 
The non-ionic detergent, Triton WR-1339, has been widely used to block the 
uptake of triacyl glycerol-rich lipoproteins from plasma by peripheral tissues in order 
to produce acute hyperlipidemia in animal models which are often used for a number 
of objectives, in particular for screening natural or chemical hypolipidemic drugs. 
With this objective, many medicinal plants have been assessed for their anti-
hyperlipidemic activity against Triton WR-1339-induced hyperlipidemia. Schurr et al. 
demonstrated that on parenteral administration of triton in adult rats maximum blood 
cholesterol and triglyceride levels were reached at 24 h, followed by a decline to 
normal values. In our study, this model gave similar plasma lipid profile changes, at 
24 h after Triton WR-1339 injection in rats. This result demonstrates the feasibility of 
using Triton induced hyperlipidemic rats as an experimental model to investigate the 
hypolipidemic effect of polyherbal extracts. Our study clearly shows that the large 
increase in serum levels of cholesterol and triglycerides due to Triton WR-1339 
injection results mostly from an increase of VLDL secretion by the liver accompanied 
by a strong reduction of VLDL and LDL catabolism. The reduction of total 
cholesterol by the hydroalcoholic extract was associated with a decrease of its LDL 
fraction in serum and liver, which is the target of several hypolipidemic drugs. Report 
of a study suggests that cholesterol lowering activity of the hydroalcoholic extract of 
polyherbal formulation could be the result of the rapid catabolism of LDL cholesterol 
through its hepatic receptors for final elimination in the form of bile acids, as 
demonstrated Increased level of serum LDL-cholesterol results in increased risk for 
the development of atherosclerosis. It is well known that HDL-Cholesterol levels have 
a protective role in coronary artery disease. HDL-cholesterol is reported to have a 
preventive function against atherogenesis since an independent inverse relationship 
between blood HDL-C levels and cardiovascular risk incidence has been reported. 
The hydroalcoholic extract of our polyherbal formulation also increased HDL-
cholesterol levels thus exhibiting antihyperlipidemic action. HMG CoA reductase is 
the rate-limiting enzyme in the cholesterol biosynthetic pathway. It converts HMG 
CoA to mevalonate. In the present study, HMG CoA reductase activity was indirectly 
measured in terms of the ratio between HMG CoA and mevalonate. The ratio was 
found to be inversely proportional to HMG CoA reductase activity, indicating that an 
increase in the ratio inferred a decrease in the enzyme activity. The hydroalcoholic 
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extract of polyherbal formulation produced a significant and dose dependent increase 
in HMG CoA / mevalonate ratio in liver as compared to normal group. Similar results 
were reported with hydroalcoholic extracts of Nasturtium officinale leaves. 
Atherosclerotic index (A.I) is believed to be an important risk factor for diagnosis of 
atherosclerosis. The hydroalcoholic extract of our polyherbal formulation reduced 
atherogenic index which is one of the most important risk factors of atherosclerotic 
plaques. Similar results were reported by others when studying the hypolipidemic 
effect of natural products. Polyherbal extract, Zizyphus jujuba contains Pectin A 
which has a number of pharmacological properties such as binding bile acid and 
lowering plasma cholesterol. Z. Jujuba contains saponins which are part of sugar 
chains which attach themselves to a sterol or triterpene. Saponins are known to form 
complexes with cholesterol by binding plasma lipids, thereby altering cholesterol 
metabolism. Capparis decidua contains saponins and tannins which inhibit lipid 
absorption. Also fibre present in Capparis deciduas has the most pronounced 
hypocholesterolemic effect which appears to operate through increased fecal 
excretion of cholesterol as well as bile acids. Thus all these constituents present in our 
polyherbal extract may be responsible for its hypolipidemic activity. 
  Thus it can be concluded that hydroalcoholic extract of------- at the dose of 
200mg/kg and 400mg/kg; p.o. showed good anti-hyperlipidemic action in Triton WR-
1339 and High cholesterol diet induced hyperlipidemia model. The probable 
mechanism of action of the extract may be inhibition of HMG-CoA reductase enzyme 
pathway. 
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